Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Nakamura

Showing results (441-450 of 475) with videos related to

Pageof 48
Sort By:
Journal of Clinical Pharmacy and Therapeutics|January 4, 2021
Albumin-bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapyShinya Shimizu, Yuichi Hayashi, Shohei Nishida, et al.
Radiation Oncology (London, England)|July 31, 2019
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)Hiroyuki Okamoto, Naoya Murakami, Fumiaki Isohashi, et al.
Journal of Applied Clinical Medical Physics|April 16, 2026
Credentialing of small-field dosimetry for the lung SBRT in Japan Clinical Oncology Group clinical trialDaisuke Kawahara, Shuichi Ozawa, Toshiyuki Minemura, et al.
SAGE Open Medicine|June 26, 2025
Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networksHideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, et al.
Oncotarget|May 29, 2018
Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linacYoko Goto, Ryo Ashida, Akira Nakamura, et al.
Biological & Pharmaceutical Bulletin|September 3, 2025
Seasonal Variation in Diuretic-Induced Dehydration Using Spontaneous Reports of Adverse EventsSatoshi Nakao, Mika Maezawa, Kohei Shiota, et al.
Frontiers in Pharmacology|January 6, 2022
Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug-gene Interaction NetworkRyogo Umetsu, Mizuki Tanaka, Yoko Nakayama, et al.
Cureus|February 4, 2025
Self-Organizing Map-Based Assessment of Immune-Related Adverse Events Caused by Immune Checkpoint InhibitorsSatoshi Nakao, Koumi Miyasaka, Mika Maezawa, et al.
Cancer Science|July 15, 2022
FOXP4 inhibits squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathwayTakeo Matsumoto, Takashi Iizuka, Mitsuhiro Nakamura, et al.
Journal of Biochemistry|April 13, 2012
Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer cell line, MCF-7Hiromi Ito, Kouji Tanaka, Kazumi Hagiwara, et al.
Pageof 48

Showing results (441-450 of 475) with videos related to

Sort By:
Pageof 48
Journal of Clinical Pharmacy and Therapeutics|January 4, 2021
Albumin-bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapyShinya Shimizu, Yuichi Hayashi, Shohei Nishida, et al.
Radiation Oncology (London, England)|July 31, 2019
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)Hiroyuki Okamoto, Naoya Murakami, Fumiaki Isohashi, et al.
Journal of Applied Clinical Medical Physics|April 16, 2026
Credentialing of small-field dosimetry for the lung SBRT in Japan Clinical Oncology Group clinical trialDaisuke Kawahara, Shuichi Ozawa, Toshiyuki Minemura, et al.
SAGE Open Medicine|June 26, 2025
Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networksHideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, et al.
Oncotarget|May 29, 2018
Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linacYoko Goto, Ryo Ashida, Akira Nakamura, et al.
Biological & Pharmaceutical Bulletin|September 3, 2025
Seasonal Variation in Diuretic-Induced Dehydration Using Spontaneous Reports of Adverse EventsSatoshi Nakao, Mika Maezawa, Kohei Shiota, et al.
Frontiers in Pharmacology|January 6, 2022
Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug-gene Interaction NetworkRyogo Umetsu, Mizuki Tanaka, Yoko Nakayama, et al.
Cureus|February 4, 2025
Self-Organizing Map-Based Assessment of Immune-Related Adverse Events Caused by Immune Checkpoint InhibitorsSatoshi Nakao, Koumi Miyasaka, Mika Maezawa, et al.
Cancer Science|July 15, 2022
FOXP4 inhibits squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathwayTakeo Matsumoto, Takashi Iizuka, Mitsuhiro Nakamura, et al.
Journal of Biochemistry|April 13, 2012
Transcriptional regulation of neutral sphingomyelinase 2 in all-trans retinoic acid-treated human breast cancer cell line, MCF-7Hiromi Ito, Kouji Tanaka, Kazumi Hagiwara, et al.
Pageof 48